Pa. Judge Axes Latest Risperdal Breast-Growth Case Mid-Trial

Law360, Philadelphia (April 17, 2017, 5:52 PM EDT) -- A Johnson & Johnson unit notched a victory on Monday as a Pennsylvania state judge issued a mid-trial decision nixing claims that an adolescent boy grew female breasts after being prescribed the antipsychotic drug Risperdal to treat symptoms of autism.

Judge Kenneth Powell in the Philadelphia County Court of Common Pleas granted a motion for compulsory nonsuit after weighing arguments from Janssen Pharmaceuticals Inc. that Dean Hibbs had been improperly diagnosed with gynecomastia — a potential side effect of Risperdal characterized by the abnormal growth of female breast tissue in men — based solely on photographs provided to an expert witness....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!